TrialHaematologica2016

Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.

Christophe Willekens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.